COMMUNIQUÉS West-GlobeNewswire

dacadoo and Bradesco Vida e Previdência Partner to Bring Digital Health Engagement to Millions in Brazil
19/05/2026
Zurich, Switzerland, May 19, 2026 (GLOBE NEWSWIRE) -- dacadoo , a Swiss-based global leader in customer engagement through its digital health engagement platform in preventative health, has entered a strategic [...]
Curia achève la modernisation de ses unités aseptiques de fabrication d’API à Valladolid, en Espagne
19/05/2026
ALBANY, N.Y., 19 mai 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), une organisation mondiale de premier plan spécialisée dans la recherche, le développement et la fabrication, a annoncé aujourd’hui l’achèvement [...]
BioSyent Announces Health Canada Approval of Thyconvi™ (levothyroxine oral solution)
19/05/2026
MISSISSAUGA, Ontario, May 19, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) announces that Health Canada has approved Thyconvi™ (levothyroxine sodium), the first and only [...]
Joshua Fritzler Named President of Olympia and Wesley Pharmaceuticals
19/05/2026
Executive promotion signals strategic growth and continued expansion of state-of-the-art 503A and 503B compounding operations ORLANDO, Fla., May 19, 2026 (GLOBE NEWSWIRE) -- Olympia and Wesley Pharmaceuticals, two of [...]
Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference
19/05/2026
Oral presentation at ERA Congress, the flagship European nephrology meeting Company expects to present additional data TORONTO, May 19, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA), a clinical-stage [...]
Capra Biosciences Launches Bioproduced Salicylic Acid for Personal Care at NYSCC Suppliers’ Day
19/05/2026
Made with cutting edge biomanufacturing technology, Capra’s salicylic acid offers formulators a high-purity, 100% plant-based and U.S.-made alternative to conventional supply NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- [...]
Curia Completes Upgrade of API Aseptic Suites in Valladolid, Spain
19/05/2026
ALBANY, N.Y., May 19, 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of its upgrade to its two aseptic suites [...]
Commure Raises $70M at $7B Valuation to Transform Healthcare Operations Using AI
19/05/2026
MOUNTAIN VIEW, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Commure , the AI platform for healthcare, today announced $70 million in financing at a $7 billion post-money valuation. The round was led by General Catalyst, [...]
Artiva Biotherapeutics Appoints Veteran Biotech Executive and Drug Developer Diego Miralles, M.D., as President and Head of Research and Development
19/05/2026
Veteran biotechnology executive with more than 20 years of leadership experience spanning research, clinical development, commercialization and company building Proven track record advancing multiple therapeutics from [...]
TRUE-See Reports New Peer-Reviewed Publication that Highlights the Critical Role of Accuracy and Quality Standards in Medical Photography
19/05/2026
TRUE-See’s patented technology is designed to make medical photography accurate, reliable and easily accessible NEW ORLEANS, May 19, 2026 (GLOBE NEWSWIRE) -- TRUE-See Systems, the global leader in calibrated [...]
AIM ImmunoTech Announces Significant Increase in Stockholder Equity and Extension of Promissory Note Maturity Date to June 2027, Enhancing Financial Flexibility and Supporting Strategic Clinical Priorities
19/05/2026
Increase in stockholder equity and note extension strengthen Company’s ability to advance pancreatic cancer development strategy OCALA, Fla., May 19, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“ [...]
BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
19/05/2026
SUNNYVALE, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, will participate [...]
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026
19/05/2026
WALTHAM, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Ardelyx Inc. (Nasdaq: ARDX), (“Ardelyx” or the “Company”) a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative [...]
Onconetix, Inc. Announces 1-for-10 Reverse Stock Split
19/05/2026
CINCINNATI, Ohio, May 19, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and commercialization of [...]
Amplexd Therapeutics Initiates Phase 2 Clinical Trial of Investigational EGCg-Based HPV Therapy
19/05/2026
GAITHERSBURG, Md., May 19, 2026 (GLOBE NEWSWIRE) -- Amplexd Therapeutics, Inc. (“Amplexd”), a U.S.-based clinical-stage biotechnology company focused on women’s health and underserved therapeutic areas, today announced [...]
SUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
19/05/2026
Patrick Hensley, MD and Daniel Joyce, MD, MS each received a grant up to $50,000.00 to support the development of outstanding clinical cancer research to improve the treatment of NMIBC Last year’s awardees recently [...]
Prana IV Therapy Highlights Emerging Research on Magnesium’s Role in Stress and Neurological Function
19/05/2026
SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- The global magnesium supplement market continues to grow (estimated at a 7–8% CAGR) as more consumers become concerned about magnesium deficiency, stress-related [...]
NKGen Biotech Expands Clinical Trial Site Network for Alzheimer’s Disease Program Across U.S. to Improve Patient Access and Support Enrollment
19/05/2026
New sites in New Jersey, New York, and Florida broaden geographic reach and increase access for patients participating in Phase 2 trial of troculeucel in moderate Alzheimer’s disease. SANTA ANA, Calif., May 19, 2026 ( [...]
Black Diamond Therapeutics to Host Webcast for Investors Highlighting Updated Results from Phase 2 Trial of Silevertinib in 1L EGFRm NSCLC
19/05/2026
Webcast will be held Thursday, May 21, 2026, at 5:30 p.m. ET CAMBRIDGE, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey [...]

Pages